Mode
Text Size
Log in / Sign up

Systematic review links gut dysbiosis to uveitis pathogenesisGut health may influence eye inflammation in uveitis

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider gut dysbiosis as a potential contributor to uveitis, but causation is unproven.

This is a systematic review examining the association between gut microbiota dysbiosis and uveitis pathogenesis. The authors synthesize proposed mechanisms by which gut dysbiosis may influence the immune status of distal organs, including molecular mimicry, modulation by microbial metabolites, disruption of intestinal immune homeostasis, and compromise of the intestinal mucosal barrier. The review does not report pooled effect sizes, study-level data, or clinical outcomes.

The authors emphasize that the evidence supports an association rather than causation. They note that the field is mechanistic and that robust clinical data are lacking. The review does not provide details on study populations, interventions, comparators, follow-up duration, or safety outcomes.

Practice relevance is not specified. Clinicians should interpret these mechanistic findings cautiously and recognize that gut microbiota modulation for uveitis remains investigational. Further high-quality trials are needed to establish whether modulating the gut microbiome alters ocular inflammation or improves patient-centered outcomes.

If you live with uveitis, you know how frustrating it can be to find what triggers flare-ups. This review looked at whether the balance of bacteria in your gut could play a role.

Researchers found an association between gut microbiota dysbiosis—an imbalance in gut bacteria—and the development of uveitis. The review suggests gut bacteria may influence the immune system in distant organs, like the eyes, through several possible ways: by affecting immune status via molecular mimicry, being modulated by microbial metabolites, disrupting intestinal immune balance, and compromising the gut's protective barrier.

The review did not report details on the specific studies included, such as the number of people involved, the settings, or direct comparisons between treatments. It also did not report any safety data or side effects. Importantly, the authors note this shows an association, not proof that gut bacteria cause uveitis. More research is needed to understand the connection and what it means for treatment.

What this means for you:
Gut bacteria imbalance may be linked to uveitis, but it's not proven to cause it.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
Uveitis is an inflammatory ocular condition that primarily affects young adults and is often associated with systemic and autoimmune disorders. This disease primarily affects intraocular structures such as the iris, ciliary body, and choroid. Clinically, it manifests through a series of symptoms, including eye redness, pain, and blurred vision, which significantly impact the quality of life for patients worldwide. Recently, the role of gut microbiota (GM) in the immune regulation and pathogenesis of inflammatory diseases has garnered significant scientific interest. This study aimed to investigate the potential association between GM and uveitis, with the objective of demonstrating novel mechanisms underlying inflammatory ocular diseases through the emerging concept of the “gut-eye axis.” Current research suggests that gut dysbiosis may influence the immune status of distal organs via various pathways, including molecular mimicry, modulation by microbial metabolites, disruption of intestinal immune homeostasis, and compromise of the intestinal mucosal barrier. Building on these mechanisms, we further explored innovative therapeutic strategies targeting GM and its metabolites, including probiotics, prebiotics, antibiotics, immunomodulators, phage therapy, fecal microbiota transplantation, and dietary interventions. This review systematically examined the association between GM dysbiosis and uveitis pathogenesis, offering new insights and directions for future research in this emerging field and establishing a theoretical foundation for developing targeted therapies based on the modulation of the microbiome.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.